Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
The European Patent Office (EPO) received more than 273 110 patent filings in 2014, an increase of around 3% over 2013, and a new all-time high. "These figures are only a first estimate, but they
light, the EPO has suggested two structures—‘True’ Top 4 and ‘True’ Top 5. Under those models, between the third and fifth years of renewal the fees would be based on the EPO’s internal renewal fees (IRF
The EPO Academic Research Programme provides financial support for rigorous research projects that set out to produce empirical evidence with relevant implications for policymakers and business in
The "positive, win-win" partnership between the EPO and its peer in China, the State Intellectual Property Office, has created an IP environment in the country that is familiar to European companies.
Due to effective measures to improve its productivity, the European Patent Office (EPO) published 96 000 granted patents in 2016, which is 40% more than in 2015 and a new high mark in its history.
The European Patent Office (EPO) has submitted proposals covering the renewal fees for the forthcoming unitary patent, with lawyers claiming that the plans may price out small businesses. Benoît
More patent applications were filed last year at the European Patent Office (EPO) than in 2013 but the total number of granted patents fell. Overall, patent filings at the office in 2014 grew by 3.1
With the upcoming UPC in mind, the President of the European Patent Office (EPO) decided that as of 1 January 2023 applicants at the EPO will be able to request a delay in the issuance of a European
Three new case studies from the EPO highlight the role of patents in growing businesses that are developing technologies to detect, diagnose and treat cancer. According to estimates by the World
The EPO is not permitted to reject patent applications based on the applicants not being identical to those in the priority application. Furthermore, no formal transfer of rights of priority is now
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
